NCT05614193 Deep Enhanced Imaging in Stroke and Vascular Neurology
| NCT ID | NCT05614193 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese PLA General Hospital |
| Condition | Radiology |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2022-12-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2022-12-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To investigate the performance of enhanced computed tomography (CT) or magnetic resonance (MR) imaging by deep learning relative to conventional CT or MR imaging in brain stroke and vascular neurology. We expect that the deep enhanced imaging method can shorten the time stay in the imaging session of stroke patients, optimize the overall imaging quality and improve the patients' care in imaging session.
Eligibility Criteria
Inclusion Criteria: * suspecting to have experienced stroke or cerebral ischemia and needed to undergo brain imaging and vascular imaging including CT or MRI * no history of kidney failure * a minimum age of 18 years * obtained written informed consent Exclusion Criteria: * severe movement artifacts * incidental finding of tumor lesion or craniocerebral surgery history * poor imaging failed to perform deep learning method * women who pregnancy
Contact & Investigator
Lou Xin
STUDY CHAIR
Chinese PLA General Hospital
Frequently Asked Questions
Who can join the NCT05614193 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Radiology. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05614193 currently recruiting?
Yes, NCT05614193 is actively recruiting participants. Contact the research team at 330322990@qq.com for enrollment information.
Where is the NCT05614193 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT05614193 clinical trial?
NCT05614193 is sponsored by Chinese PLA General Hospital. The principal investigator is Lou Xin at Chinese PLA General Hospital. The trial plans to enroll 1,000 participants.